vs
Side-by-side financial comparison of HARTE HANKS INC (HHS) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $39.9M, roughly 1.9× HARTE HANKS INC). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -15.4%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-686.0K). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -6.4%).
Harte Hanks is a global marketing services company headquartered in Boston, Massachusetts. Harte Hanks services include analytics, strategy, marketing technology, creative services, digital marketing, customer care, direct mail, logistics, and fulfillment.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
HHS vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.9M | $75.5M |
| Net Profit | $2.2M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | -0.3% | 22.7% |
| Net Margin | 5.5% | — |
| Revenue YoY | -15.4% | 27.7% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.30 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.9M | $75.5M | ||
| Q3 25 | $39.5M | $54.5M | ||
| Q2 25 | $38.6M | $52.4M | ||
| Q1 25 | $41.6M | $46.0M | ||
| Q4 24 | $47.1M | $59.1M | ||
| Q3 24 | $47.6M | $80.5M | ||
| Q2 24 | $45.0M | $47.1M | ||
| Q1 24 | $45.4M | $43.8M |
| Q4 25 | $2.2M | — | ||
| Q3 25 | $-2.3M | $8.8M | ||
| Q2 25 | $-335.0K | $5.9M | ||
| Q1 25 | $-392.0K | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $142.0K | $20.3M | ||
| Q2 24 | $-27.8M | $-4.5M | ||
| Q1 24 | $-171.0K | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | -0.3% | 22.7% | ||
| Q3 25 | 1.3% | 17.6% | ||
| Q2 25 | 0.1% | 12.7% | ||
| Q1 25 | -0.1% | 8.7% | ||
| Q4 24 | -3.3% | 22.6% | ||
| Q3 24 | 4.0% | 27.4% | ||
| Q2 24 | 3.0% | -4.6% | ||
| Q1 24 | 0.8% | -5.3% |
| Q4 25 | 5.5% | — | ||
| Q3 25 | -5.8% | 16.2% | ||
| Q2 25 | -0.9% | 11.2% | ||
| Q1 25 | -0.9% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.3% | 25.2% | ||
| Q2 24 | -61.8% | -9.6% | ||
| Q1 24 | -0.4% | -11.0% |
| Q4 25 | $0.30 | $0.26 | ||
| Q3 25 | $-0.31 | $0.17 | ||
| Q2 25 | $-0.05 | $0.12 | ||
| Q1 25 | $-0.05 | $0.06 | ||
| Q4 24 | $-0.31 | $0.40 | ||
| Q3 24 | $0.02 | $0.41 | ||
| Q2 24 | $-3.84 | $-0.09 | ||
| Q1 24 | $-0.02 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.6M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $20.5M | $130.3M |
| Total Assets | $91.8M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $97.5M | ||
| Q3 25 | $6.5M | $94.4M | ||
| Q2 25 | $4.8M | $96.0M | ||
| Q1 25 | $9.0M | $93.2M | ||
| Q4 24 | $9.8M | $101.0M | ||
| Q3 24 | $5.9M | $96.7M | ||
| Q2 24 | $11.0M | $96.8M | ||
| Q1 24 | $11.5M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $20.5M | $130.3M | ||
| Q3 25 | $19.9M | $115.3M | ||
| Q2 25 | $22.2M | $104.7M | ||
| Q1 25 | $21.4M | $97.1M | ||
| Q4 24 | $21.7M | $92.1M | ||
| Q3 24 | $21.0M | $71.1M | ||
| Q2 24 | $20.6M | $48.5M | ||
| Q1 24 | $20.0M | $51.0M |
| Q4 25 | $91.8M | $216.3M | ||
| Q3 25 | $92.7M | $202.9M | ||
| Q2 25 | $95.0M | $194.9M | ||
| Q1 25 | $100.6M | $196.2M | ||
| Q4 24 | $101.8M | $213.3M | ||
| Q3 24 | $108.1M | $220.7M | ||
| Q2 24 | $109.7M | $205.0M | ||
| Q1 24 | $113.4M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $737.0K | $14.4M |
| Free Cash FlowOCF − Capex | $-686.0K | $14.4M |
| FCF MarginFCF / Revenue | -1.7% | 19.1% |
| Capex IntensityCapex / Revenue | 3.6% | 0.0% |
| Cash ConversionOCF / Net Profit | 0.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-4.5M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $737.0K | $14.4M | ||
| Q3 25 | $3.2M | $9.7M | ||
| Q2 25 | $-4.8M | $14.1M | ||
| Q1 25 | $-818.0K | $3.6M | ||
| Q4 24 | $4.0M | $15.6M | ||
| Q3 24 | $-2.9M | $11.0M | ||
| Q2 24 | $1.6M | $1.0M | ||
| Q1 24 | $-5.7M | $11.2M |
| Q4 25 | $-686.0K | $14.4M | ||
| Q3 25 | $2.2M | $9.7M | ||
| Q2 25 | $-5.1M | $14.1M | ||
| Q1 25 | $-923.0K | $3.6M | ||
| Q4 24 | $3.4M | $15.6M | ||
| Q3 24 | $-4.9M | $11.0M | ||
| Q2 24 | $926.0K | $1.0M | ||
| Q1 24 | $-6.2M | — |
| Q4 25 | -1.7% | 19.1% | ||
| Q3 25 | 5.5% | 17.7% | ||
| Q2 25 | -13.1% | 26.8% | ||
| Q1 25 | -2.2% | 7.7% | ||
| Q4 24 | 7.3% | 26.4% | ||
| Q3 24 | -10.2% | 13.7% | ||
| Q2 24 | 2.1% | 2.1% | ||
| Q1 24 | -13.7% | — |
| Q4 25 | 3.6% | 0.0% | ||
| Q3 25 | 2.5% | 0.0% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 0.3% | 0.1% | ||
| Q4 24 | 1.3% | 0.0% | ||
| Q3 24 | 4.0% | 0.0% | ||
| Q2 24 | 1.5% | 0.0% | ||
| Q1 24 | 1.2% | 0.0% |
| Q4 25 | 0.33× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -20.76× | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HHS
| Fulfillment And Logistics Services | $17.3M | 43% |
| Customer Care | $13.7M | 34% |
| Other | $8.9M | 22% |
PBYI
Segment breakdown not available.
